SCHEMBL25682136

SCHEMBL25682136

c1ccc(-c2ccc3cc(-c4cccc5oc6c7ccccc7c(-c7nc(-c8ccccc8)nc(-c8ccccc8)n7)cc6c45)ccc3c2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.40
PIM1 P11309 1/20 0.36
CSNK2A2 P19784 1/20 0.36
CSNK2B P67870 1/20 0.36
PIM3 Q86V86 1/20 0.36
PIM2 Q9P1W9 1/20 0.36
PGR P06401 1/20 0.35
ALDH1A1 P00352 5/20 0.35
KDM4E B2RXH2 3/20 0.35
HSD17B10 Q99714 3/20 0.35
TP53 P04637 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
KMT2A Q03164 2/20 0.35
MEN1 O00255 1/20 0.35
CYP1A2 P05177 1/20 0.35
MAPT P10636 5/20 0.34
TSHR P16473 3/20 0.34
HPGD P15428 2/20 0.34
NFKB1 P19838 1/20 0.34
MAPK1 P28482 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24586075 0.96 ALOX5 (0.36) ALOX5PIM1CSNK2A2CSNK2BPIM3
SCHEMBL25681968 0.96 ALDH1A1 (0.39) ALOX5PIM1CSNK2A2CSNK2BPIM3
SCHEMBL26243910 0.96 ALDH1A1 (0.39) ALOX5PIM1CSNK2A2CSNK2BPIM3
SCHEMBL25682137 0.96 ALDH1A1 (0.37) ALOX5PIM1CSNK2A2CSNK2BPIM3
SCHEMBL25679422 0.95 ALDH1A1 (0.39) ALOX5PIM1CSNK2A2CSNK2BPIM3
SCHEMBL25679332 0.95 ALDH1A1 (0.39) ALOX5PIM1CSNK2A2CSNK2BPIM3
SCHEMBL25676130 0.95 ALDH1A1 (0.39) ALOX5PIM1CSNK2A2CSNK2BPIM3
SCHEMBL25681970 0.94 ALOX5 (0.38) ALOX5PIM1CSNK2A2CSNK2BPIM3
SCHEMBL26243955 0.94 ALDH1A1 (0.38) ALOX5PIM1CSNK2A2CSNK2BPIM3
SCHEMBL24586060 0.94 ALDH1A1 (0.39) ALOX5ALDH1A1KDM4EHSD17B10TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230292601-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2023-09-14 US disclosed
US-20230292601-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2023-09-14 US disclosed
EP-4201931-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT Materials Co., Ltd. (KR) 2023-06-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230292601-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME ORC3, CRY1, SUN2 ALOX5 828/4885PIM1 1348/4885CSNK2A2 2634/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.